Delivery Order SPE2DB20D1100-SPE2DB25FD9L9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,720.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml, a pharmaceutical product, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $16,321.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TREMFYA 100 MG/ML pharmaceutical product. This is an unset-aside, competitively awarded contract with performance to be completed by September 24, 2025, and performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.40 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive procurement of a specialized pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing...
- The Defense Logistics Agency awarded a delivery order valued at $14,510.52 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with a completion date of July 25, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,751.91 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical product, with a completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract awarded on July 24, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $21,941.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical supply on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $43,531.56 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9L9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,978.26 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, on August 8, 2025, with completion targeted for August 11, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The prime IDC enables the contractor to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible procurement mechanisms aligned with DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 8/8/25 |